THERMACARE Pain gel, 50 g

Instructions for use for THERMACARE Pain gel, 50 g

Detailed instructions for THERMACARE Pain gel, 50 g

Field of use

• The drug is a pain relieving and anti -inflammatory medicine for external use.
• It is used in adults and adolescents aged 14 and over for the treatment of pain
  • acute strains, sprains or bruises in the area of limbs as a result of sports and accident injuries
  • Inflammatory soft tissue rheumatic diseases such as tendonitis, tendonitis, inflammation of the tendonitis, bursitis.

Mode of action

The Thermacare pain gel (pack size: 50 g) has a triple - cooling, pain -relieving and anti -inflammatory

Active ingredients / ingredients / ingredients

Thermacare pain gel (pack size: 50 g) contains:

48.8 mg Felbinac-1,1 'IMinobis (Propan-2-OL)
30 mg Felbinac
1,1'-Iminodipropan-2-ol Hedge substance (+)
Carbomer auxiliary substance (+)
Ethanol Hedge substance (+)
Water, cleaned auxiliary material (+)

Contradictions

• The pain gel must not be used
  • if they are hypersensitive to Felbinac or certain other anti -inflammatory medicines (non -steroidal anti -inflammatory drugs, including acetylsalicylic acid), or one of the other components of the drug.

dosage

• The following information applies unless your doctor has prescribed the drug. Please adhere to the application regulations, otherwise the medicine cannot work properly!
• Unless otherwise prescribed, 1 - 2 g gel (approx. 3 - 6 cm gel strand) are applied 2 to 4 times a day to the painful parts and slightly massaged. If a significant improvement has occurred, treatment with lower daily doses should continue.
• A daily dose of 20 g gel should not be exceeded regardless of the size of the area to be treated.

 

• What else do you need to look out for?
  • There is no experience for overdose and symptoms with the pain gel and its consequences.

 

• Duration of the application
  • The medicine should be used until the symptoms subsided.
  • If there is no improvement in the symptoms during the treatment, the doctor must be visited.

Taking

• For application on the skin.
• The gel must be applied to the aching games and easy to massage.
• It may only be applied to uninjured skin. The contact with mucous membranes or eyes should be avoided.
• The gel should not be used under densely final associations.

Patient information

• Special care in the application is required
  • Patients with pre -damaged kidney and patients who are on non -steroidal inflammatory inhibitors or pain relievers in an earlier application. B. with asthma attacks, skin reactions, acute runny nose or certain kidney diseases (nephrotic syndrome or interstitial nephritis) have been hypersensitive, this medicine should not apply. If you are among the patients mentioned, speak to your doctor before using the drug.
  • The gel should be at childrn and adolescents under the age of 14 are not used, since there are no sufficient examinations for this age group.

 

• Wateriness and ability to operate machines
  • There is no data on the influence of this drug on the traffic or operating machines.

Pregnancy

• Ask your doctor or pharmacist for advice before taking/using all drugs.
• Pregnancy
  • There is no sufficient experiences about the use of Felbinac during pregnancy. Therefore, the gel should not be used during pregnancy.
• Breastfeeding
  • Until further experience is available, the medicine should not be used during breastfeeding.

Hints

Manufacturer:  Angelini Pharma Deutschland GmbH, Martin-Greif-Straße 1